SENS MEXC RealStocks
Own real SENS shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-16 19:44:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Senseonics Holdings, Inc. (SENS) operates in the INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL sector and is listed on NASDAQ. The stock is currently priced at $10.97, with a market capitalization of $579.58M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.79 to $13.98. This page covers its latest market performance, valuation, price trends and company information.
$579.58M | |
$10.34 | |
$11.50 | |
$10.27 | |
$10.58 | |
2.32M | |
773.75K | |
-- | |
$13.98 | |
$4.79 | |
-- | |
-- |
Senseonics Holdings, Inc. (SENS) is currently trading at $10.97 as of 2026-11-16 19:43:00, up 4.25% ($0.45) from the previous close of $10.58
During today's regular trading session, SENS has traded between $10.27 and $11.50, with a trading volume of 2.32M shares. The current price is near the middle of today's range.
Over the past seven days, Senseonics Holdings, Inc. (SENS) moved from $7.99 to $10.97, representing a gain of 37.33% ($2.98).
The stock traded between $7.83 and $13.98 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 1.53 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 67.3%
SENS is currently trading at $10.97, placing it 67.3% of the way from its 52-week low of $4.79 to its 52-week high of $13.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
| Industry | INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL |
| Employees | 130 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Senseonics Holdings, Inc. (SENS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SENS, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SENS shares and USD.
SENS Shares to USD
1.00 SENS shares = 10.973 USD
Calculations are estimates based on the latest available price and are for reference only.